Celecoxib effect in a multiresistant variant of the TA3 tumor. A histological description;Efecto de celecoxib en una variante multirresistente del tumor TA3. Una descripción histológica

International Journal of Morphology

Volumn 31, Issue 2, 2013, Pages 392-398

  Rosas C , Carlos ^a   Roa, Ignacio ^a,b   Sinning O , Mariana ^a   Fuenzalida B , Marcela ^a   Lemus A , David ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b UNIVERSIDAD DE TALCA   (Chile)

Author keywords

Angiogenesis; Celecoxib; Tumor

Indexed keywords

EID: 84884781650     PISSN: 07179367     EISSN: 07179502     Source Type: Journal    
DOI: 10.4067/S0717-95022013000200005     Document Type: Article

References (17)

1. Amrite, A. C.; Ayalasomayajula, S. P.; Cheruvu, N. P. & Kompella, U. B. Single periocular injection of celecoxib-PLGA microparticles inhibits diabetes-induced elevations in retinal PGE2, VEGF, and vascular leakage. Invest. Ophthalmol. Vis. Sci., 47(3):1149-60, 2006.
2. Cianchi, F. C.; Cortesini, P.; Bechi, O.; Fantappiè, L.; Messerini, A.; Vannacci, I.; Sardi, G.; Baroni, V.; Boddi, R.; Mazzanti, & Masini, E. Up-regulation of cyclooxygenase 2 gene expression correlates with tumor angiogenesis in human colorectal cancer. Gastroenterology, 121:1339-47, 2001.
3. Copelli, G.; Guaita, E.; Spaggiari, S. & Coruzzi, G. Gastric effects of the selective cyclooxygenase-2 inhibitor, celecoxib, in the rat. Digestive and Liver Disease, 36:265-70, 2004.
4. Dempke, W.; Rie, C. Grothey, A.; & Schmoll, H. Cyclooxygenase-2: a novel target for cancer chemotherapy? J. Cancer Res. Clin. Oncol., 127:411-7, 2001.
5. Farooqui, M.; Li, Y.; Rogers, T. Poonawala, T.; Griffin, R.; Song, C & Gupta, K. COX-2 inhibitor celecoxib prevents chronic morphineinduced promotion of angiogenesis, tumour growth, metastasis, and mortality, without compromising analgesia. British J. Cancer, 97:1523-31, 2007.
6. Gajardo, P.; Cordano, G.; Pavani, M.; Muñoz, S.; Rivera, E.; Medina, J.; Guerrero, A. & Ferreira, J. La inhibición de la respiración mitocondrial por el ester 2,6-dihidroxi-4-carboxifenoxiacetato de bis isopropilo (Carfenisop) y su papel como restaurador de la sensibilidad a fármacos antineoplásicos en el cárcinoma multirresistente Ta3-MTX-R trasplantable de ratón. Rev. Chil. Cancerología y Hematología, 11:162-74, 2001.
7. Guerrero, A.; Zipper, J. & Dabancens, A. Actividad antineoplásica ejercida por Quinacrina oral sobre tumores malignos trasplantables en ratón. Rev. Chil. Cancerología y Hematología, 2:119-22, 1992.
8. a ed. Editorial Elsevier Madrid, 2005.
9. Ragel, B.; Jensen, R.; Gillespie, D.; Prescott, S. & Couldwell, W. Celecoxib inhibits meningioma tumor growth in a mouse xenograft model. Cancer, 109:588-97, 2007.
10. Silverstein, F.; Faich, G.; Goldstein, J.; Simon, L.; Pincus, T.; Whelton, A.; Makuch, R.; Eisen, G.; Agrawal, N.; Stenson, W.; Burr, A.; Zhao, W.; Kent, J.; Lefkowith, J.; Verburg, K. & Geis, G. S. Gastrointestinal Toxicity with Celecoxib v/s Nonsteroidal anti-inflammatory drugs for Osteoarthritis and rheumatoid arthritis. JAMA, 284:1247-55. 2000.
11. Thomson, A. NSAID-induced gastric damage in rats. Can. J. Gastroenterol., 15:553, 2001.
12. Tosetti, F.; Ferrari, N.; De Flora, S. & Albini, A. Angioprevention: angiogénesis is a common key target for cancer Chemopreventive agents. FASEB, 16:2-14, 2002.
13. Wolfe, M.; Lichtenstein, D. & Singh, G. Gastrointestinal Toxicity of nonsteroidal anti-inflammatory drugs. N. Engl. J. Med., 340:1888-99, 1999.
14. Xiao, H.; Zhang, Q.; Lin, Y.; Reddy, B. & Yang, C. Combination of atorvastatin and celecoxib synergistically induces cell cycle arrest and apoptosis in colon cancer cells. Int. J. Cancer., 122:2115-24, 2008.
15. Xu, X.; Xie, C.; Wang, X.; Liu, J.; Yu, Y.; Hu, H. & Guo, C. Selective inhibition of cycloooxygenase-2 suppresses the growth of pancreatic cancer cells in vitro and in vivo. Tohoku J. Exp. Med., 215:149-57, 2008.
16. Zipper, J.; Dabances, A.; Guerrero, A. & Trujillo, V. Quinacrine Revised. Human Reprod. Update, 1(4):324-42, 1995.
17. Zhou, Y.; Ran, J.; Tang, C.; Wu, J.; Honghua, L.; Xingwen, L.; Ning, C. & Qiao, L. Effect of Celecoxib on E-cadherin, VEGF, Microvessel Density and Apoptosis in Gastric Cancer. Cancer Biol & Ther., 6:e1-7, 2007.